RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P

Open source

DOI: 10.1172/jci.insight.127552
Published: 2019 Jun 25
Container: JCI insight
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.127552,
  title = {RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.},
  author = {Gbenedio OM and Bonnans C and Grun D and Wang CY and Hatch AJ and Mahoney MR and Barras D and Matli M and Miao Y and Garcia KC and Tejpar S and Delorenzi M and Venook AP and Nixon AB and Warren RS and Roose JP and Depeille P},
  year = {2019},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.127552},
  url = {https://doi.org/10.1172/jci.insight.127552}
}

RIS

TY  - JOUR
TI  - RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
AU  - Gbenedio OM
AU  - Bonnans C
AU  - Grun D
AU  - Wang CY
AU  - Hatch AJ
AU  - Mahoney MR
AU  - Barras D
AU  - Matli M
AU  - Miao Y
AU  - Garcia KC
AU  - Tejpar S
AU  - Delorenzi M
AU  - Venook AP
AU  - Nixon AB
AU  - Warren RS
AU  - Roose JP
AU  - Depeille P
PY  - 2019
JO  - JCI insight
DO  - 10.1172/jci.insight.127552
UR  - https://doi.org/10.1172/jci.insight.127552
ER  -

APA

OM, G., C, B., D, G., CY, W., AJ, H., MR, M., D, B., M, M., Y, M., KC, G., S, T., M, D., AP, V., AB, N., RS, W., JP, R., & P, D. (2019). RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.. JCI insight. https://doi.org/10.1172/jci.insight.127552

Source records

pubmed · retrieved 2026-09-25T10:47:09.577Z